Edwards Lifesciences Net Income 2006-2018 | EW

Edwards Lifesciences annual and quarterly net income history from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Edwards Lifesciences net income for the quarter ending June 30, 2018 was $0.283B, a 51.91% increase year-over-year.
  • Edwards Lifesciences net income for the twelve months ending June 30, 2018 was $0.657B, a 8.32% decline year-over-year.
  • Edwards Lifesciences annual net income for 2017 was $0.584B, a 2.48% increase from 2016.
  • Edwards Lifesciences annual net income for 2016 was $0.57B, a 15.07% increase from 2015.
  • Edwards Lifesciences annual net income for 2015 was $0.495B, a 38.98% decline from 2014.
Edwards Lifesciences Annual Net Income
(Millions of US $)
2017 $584
2016 $570
2015 $495
2014 $811
2013 $389
2012 $292
2011 $237
2010 $218
2009 $229
2008 $129
2007 $113
2006 $131
2005 $79
Edwards Lifesciences Quarterly Net Income
(Millions of US $)
Q2 2018 $283
Q1 2018 $207
Q4 2017 $-3
Q3 2017 $170
Q2 2017 $186
Q1 2017 $230
Q4 2016 $159
Q3 2016 $141
Q2 2016 $127
Q1 2016 $143
Q4 2015 $141
Q3 2015 $118
Q2 2015 $113
Q1 2015 $123
Q4 2014 $109
Q3 2014 $95
Q2 2014 $547
Q1 2014 $60
Q4 2013 $75
Q3 2013 $77
Q2 2013 $93
Q1 2013 $144
Q4 2012 $89
Q3 2012 $69
Q2 2012 $68
Q1 2012 $65
Q4 2011 $63
Q3 2011 $52
Q2 2011 $58
Q1 2011 $64
Q4 2010 $65
Q3 2010 $48
Q2 2010 $58
Q1 2010 $48
Q4 2009 $48
Q3 2009 $74
Q2 2009 $48
Q1 2009 $61
Q4 2008 $38
Q3 2008 $33
Q2 2008 $40
Q1 2008 $18
Q4 2007 $16
Q3 2007 $29
Q2 2007 $35
Q1 2007 $33
Q4 2006 $21
Q3 2006 $28
Q2 2006 $36
Q1 2006 $46
Q4 2005 $39
Q3 2005 $-4
Q2 2005 $14
Q1 2005 $31
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $30.560B $3.435B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $96.309B 23.10
Intuitive Surgical (ISRG) United States $64.247B 61.33
Fresenius Medical Care (FMS) Germany $31.552B 22.29
IDEXX Laboratories (IDXX) United States $21.234B 64.53
ABIOMED (ABMD) United States $16.899B 138.44
Teleflex (TFX) United States $12.316B 29.30
DexCom (DXCM) United States $12.309B 0.00
Hologic (HOLX) United States $11.021B 18.75
Varian Medical Systems (VAR) United States $10.197B 25.67
STERIS (STE) United Kingdom $9.685B 26.64
Masimo (MASI) United States $6.374B 42.44
LivaNova (LIVN) United Kingdom $6.051B 36.10
Inogen (INGN) United States $5.634B 149.09
Integra LifeSciences Holdings (IART) United States $5.391B 27.90
Penumbra (PEN) United States $5.231B 475.47
Globus Medical (GMED) United States $5.190B 34.52
Cantel Medical (CMD) United States $4.053B 42.25
Halyard Health (AVNS) United States $3.306B 27.21
Wright Medical Group (WMGI) Netherlands $2.924B 0.00
Integer Holdings (ITGR) United States $2.612B 23.65
Opko Health (OPK) United States $2.362B 0.00
Tandem Diabetes Care (TNDM) United States $2.253B 0.00
Glaukos (GKOS) United States $2.176B 1246.80
Nevro (NVRO) United States $1.747B 0.00
AxoGen (AXGN) United States $1.360B 0.00
Luminex (LMNX) United States $1.346B 39.71
Mazor Robotics (MZOR) Israel $1.318B 0.00
TransEnterix (TRXC) United States $1.298B 0.00
CryoLife (CRY) United States $1.269B 111.29
Tactile Systems Technology (TCMD) United States $1.219B 207.75
Accelerate Diagnostics (AXDX) United States $1.218B 0.00
K2Ms (KTWO) United States $1.189B 0.00
Natus Medical (BABY) United States $1.164B 24.68
Orthofix (OFIX) United States $1.008B 30.71
Intersect ENT (XENT) United States $0.915B 0.00
AngioDynamics (ANGO) United States $0.870B 32.14
ViewRay (VRAY) United States $0.703B 0.00
Mesa Laboratories (MLAB) United States $0.698B 43.17
Sientra (SIEN) United States $0.687B 0.00
Pacific Biosciences Of California (PACB) United States $0.668B 0.00
Neuronetics (STIM) United States $0.596B 0.00
GenMark Diagnostics (GNMK) United States $0.426B 0.00
OrthoPediatrics (KIDS) United States $0.416B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.412B 0.00
Quotient (QTNT) Switzerland $0.366B 0.00
Veracyte (VCYT) United States $0.363B 0.00
Accuray (ARAY) United States $0.342B 0.00
IRadimed (IRMD) United States $0.336B 120.96
Fluidigm (FLDM) United States $0.323B 0.00
CRH Medical (CRHM) Canada $0.309B 38.64
Nuvectra (NVTR) United States $0.297B 0.00
T2 Biosystems (TTOO) United States $0.276B 0.00
RTI Surgical (RTIX) United States $0.276B 54.38
Corindus Vascular Robotics (CVRS) United States $0.263B 0.00
Pulse Biosciences (PLSE) United States $0.244B 0.00
SeaSpine Holdings (SPNE) United States $0.226B 0.00
Helius Medical Technologies (HSDT) United States $0.225B 0.00
Invuity (IVTY) United States $0.177B 0.00
Apollo Endosurgery (APEN) United States $0.162B 0.00
Alphatec Holdings (ATEC) United States $0.139B 0.00
Ekso Bionics Holdings (EKSO) United States $0.130B 0.00
Second Sight Medical Products (EYES) United States $0.119B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.117B 0.00
Sensus Healthcare (SRTS) United States $0.109B 0.00
Viveve Medical (VIVE) United States $0.097B 0.00
EDAP TMS (EDAP) France $0.079B 0.00
ConforMIS (CFMS) United States $0.077B 0.00
Restoration Robotics (HAIR) United States $0.075B 0.00
Xtant Medical Holdings (XTNT) United States $0.052B 0.00
Electromed (ELMD) United States $0.049B 26.95
Navidea Biopharmaceuticals (NAVB) United States $0.047B 0.00
Neovasc (NVCN) Canada $0.047B 0.00
OBALON THERPTCS (OBLN) United States $0.046B 0.00
Vermillion (VRML) United States $0.045B 0.00
PAVmed (PAVM) United States $0.034B 0.00
ReWalk Robotics (RWLK) Israel $0.032B 0.00
Presbia (LENS) Ireland $0.030B 0.00
Titan Medical (TMDI) Canada $0.030B 0.00
Lianluo Smart (LLIT) China $0.030B 0.00
Dynatronics (DYNT) United States $0.025B 0.00
DarioHealth (DRIO) Israel $0.021B 0.00
American Shared Hospital Services (AMS) United States $0.018B 14.09
Nanovibronix (NAOV) United States $0.017B 0.00
Bioanalytical Systems (BASI) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Avinger (AVGR) United States $0.016B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Micron Solutions (MICR) United States $0.010B 0.00
Allied Healthcare Products (AHPI) United States $0.009B 0.00
Cesca Therapeutics (KOOL) United States $0.008B 0.00
Sunshine Heart Inc (CHFS) United States $0.008B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
Amedica (AMDA) United States $0.003B 0.00
EnteroMedics (RSLS) United States $0.000B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00